ArticleNeurosurgery practice2025
The Impact of Metastatic Brain Lesions on Enhanced Recovery After Surgery Protocols for Elective and Emergent Supratentorial Brain Tumor Surgery: A Retrospective Review.
Article in Neurosurgery practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Outpatient supratentorial craniotomy for brain lesions: a pilot feasibility and safety study.Neurosurgical review · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesEnhanced Recovery After Surgery protocols are increasingly being used in neurosurgery, with multiple postoperative day (POD) zero and POD1 discharge protocols being implemented for patients undergoing craniotomies for brain tumor resection. We discuss our experience with implementing a POD1 protocol for patients both admitted electively and from the emergency department (ED).
methodsWe conducted a retrospective cohort study of 61 consecutive patients treated with craniotomies for brain tumor resection at Jersey Shore University Medical Center by a single surgeon from August 2022 to April 2024.
resultsA total of 39 patients met the inclusion criteria for POD1 discharge protocol. Of these 33.3% (n = 13) were successfully discharged on POD1, whereas 38.5% (n = 15) were cleared by neurosurgery on POD1 but required additional management before discharge. There were 7 ED visits and readmissions within 30 days, of which 3 were neurosurgery related. One patient had a planned reoperation, another patient had rapid tumor recurrence, and the third patient had symptomatic hyponatremia. There were no statistically significant differences in hospital stay between patients admitted electively vs through the ED. The only statistically significant factor was metastatic disease. Specifically, patients with metastatic disease had significantly longer hospital stays (t = 2.14 days,
conclusionWe found no statistically significant difference between elective and ED admitted patients regarding hospital length of stay or discharge delay, suggesting that both cohorts can successfully participate in this protocol. The only significant delaying factor was metastatic disease, with many patients presenting with brain tumors as the first sign of underlying malignancy. We suggest that for patients with metastatic disease to the brain, only patients with established cancer diagnoses be included in these Enhanced Recovery After Surgery protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.